Evidence map›Paper›PMID 38732504›Full record

ArticleNutrients2024

Inhibition of Prostate Cancer Cell Survival and Proliferation by Carnosic Acid Is Associated with Inhibition of Akt and Activation of AMPK Signaling.

Matteo Nadile, Newman Siu Kwan Sze, Val A Fajardo, Evangelia Tsiani

Abstract read
In one paragraph

Article in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Matteo NadileDepartment of Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada.ORCID 0000-0002-5516-9175
Newman Siu Kwan SzeDepartment of Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada.ORCID 0000-0002-5652-1687
Val A FajardoDepartment of Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada.ORCID 0000-0003-4500-3347
Evangelia TsianiDepartment of Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer, accounting for 375,304 deaths in 2020, is the second most prevalent cancer in men worldwide. While many treatments exist for prostate cancer, novel therapeutic agents with higher efficacy are needed to target aggressive and hormone-resistant forms of prostate cancer, while sparing healthy cells. Plant-derived chemotherapy drugs such as docetaxel and paclitaxel have been established to treat cancers including prostate cancer. Carnosic acid (CA), a phenolic diterpene found in the herb rosemary (Rosmarinus officinalis) has been shown to have anticancer properties but its effects in prostate cancer and its mechanisms of action have not been examined. CA dose-dependently inhibited PC-3 and LNCaP prostate cancer cell survival and proliferation (IC

Indexed as

AbietanesAMP-Activated Protein KinasesCell ProliferationCell SurvivalProstatic NeoplasmsProto-Oncogene Proteins c-aktSignal TransductionAntineoplastic Agents, PhytogenicCell Line, TumorHumansMalePC-3 CellsPhosphorylationTOR Serine-Threonine KinasesAbietanesAMP-Activated Protein KinasesAntineoplastic Agents, PhytogenicProto-Oncogene Proteins c-aktsalvinTOR Serine-Threonine KinasesAktAMPKcarnosic acidproliferationprostate cancerSestrin-2survival

Identifiers

PMID38732504
PMCPMC11085396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.